Evolving Treatment Strategies for Neuropathic Pain: A Narrative Review.<\/title><secondary-title>Medicina (Kaunas, Lithuania)<\/secondary-title><\/titles><dates><year>2025<\/year><\/dates><electronic-resource-num>10.3390\/medicina61061063<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.mdpi.com\/1648-9144\/61\/6\/1063\/pdf?version=1749542630<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>2<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Fagan HA<\/author><author>Baldwin DS<\/author><\/authors><\/contributors><titles><title>Pharmacological Treatment of Generalised Anxiety Disorder: Current Practice and Future Directions.<\/title><secondary-title>Expert review of neurotherapeutics<\/secondary-title><\/titles><dates><year>2023<\/year><\/dates><electronic-resource-num>10.1080\/14737175.2023.2211767<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737175.2023.2211767?needAccess=true&role=button<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>3<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Borgert BJ<\/author><author>Wallen EM<\/author><author>Pham MN<\/author><\/authors><\/contributors><titles><title>Prostatitis: A Review.<\/title><secondary-title>JAMA<\/secondary-title><\/titles><dates><year>2025<\/year><\/dates><electronic-resource-num>10.1001\/jama.2025.11499<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>4<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Strzelczyk A<\/author><author>Schubert-Bast S<\/author><\/authors><\/contributors><titles><title>Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies.<\/title><secondary-title>CNS drugs<\/secondary-title><\/titles><dates><year>2022<\/year><\/dates><electronic-resource-num>10.1007\/s40263-022-00955-9<\/electronic-resource-num><urls><related-urls><url>https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-022-00955-9.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>5<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Safarpour Y<\/author><author>Vaziri ND<\/author><author>Jabbari B<\/author><\/authors><\/contributors><titles><title>Restless Legs Syndrome in Chronic Kidney Disease- a Systematic Review.<\/title><secondary-title>Tremor and other hyperkinetic movements (New York, N.Y.)<\/secondary-title><\/titles><dates><year>2023<\/year><\/dates><electronic-resource-num>10.5334\/tohm.752<\/electronic-resource-num><urls><related-urls><url>https:\/\/storage.googleapis.com\/jnl-up-j-tohm-files\/journals\/1\/articles\/752\/6424233a93752.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>6<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Huerta M\u00c1<\/author><author>Garcia MM<\/author><author>Garc\u00eda-Parra B et al.<\/author><\/authors><\/contributors><titles><title>Investigational Drugs for the Treatment of Postherpetic Neuralgia: Systematic Review of Randomized Controlled Trials.<\/title><secondary-title>International journal of molecular sciences<\/secondary-title><\/titles><dates><year>2023<\/year><\/dates><electronic-resource-num>10.3390\/ijms241612987<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.mdpi.com\/1422-0067\/24\/16\/12987\/pdf?version=1692511286<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>7<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Meaadi J<\/author><author>Obara I<\/author><author>Eldabe S et al.<\/author><\/authors><\/contributors><titles><title>The safety and efficacy of gabapentinoids in the management of neuropathic pain: a systematic review with meta-analysis of randomised controlled trials.<\/title><secondary-title>International journal of clinical pharmacy<\/secondary-title><\/titles><dates><year>2023<\/year><\/dates><electronic-resource-num>10.1007\/s11096-022-01528-y<\/electronic-resource-num><urls><related-urls><url>https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-022-01528-y.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>8<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>Pregabalin.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2006<\/year><\/dates><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>9<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Cernea S<\/author><author>Raz I<\/author><\/authors><\/contributors><titles><title>Management of diabetic neuropathy.<\/title><secondary-title>Metabolism: clinical and experimental<\/secondary-title><\/titles><dates><year>2021<\/year><\/dates><electronic-resource-num>10.1016\/j.metabol.2021.154867<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>10<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Tang J<\/author><author>Zhang Y<\/author><author>Liu C et al.<\/author><\/authors><\/contributors><titles><title>Therapeutic Strategies for Postherpetic Neuralgia: Mechanisms, Treatments, and Perspectives.<\/title><secondary-title>Current pain and headache reports<\/secondary-title><\/titles><dates><year>2023<\/year><\/dates><electronic-resource-num>10.1007\/s11916-023-01146-x<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>11<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>D'Souza RS<\/author><author>Barman R<\/author><author>Joseph A et al.<\/author><\/authors><\/contributors><titles><title>Evidence-Based Treatment of Painful Diabetic Neuropathy: a Systematic Review.<\/title><secondary-title>Current pain and headache reports<\/secondary-title><\/titles><dates><year>2022<\/year><\/dates><electronic-resource-num>10.1007\/s11916-022-01061-7<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>12<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Swati Shinde<\/author><author>Meena Yadav<\/author><author>Santosh waghmare<\/author><\/authors><\/contributors><titles><title>Quality by Design Based RP-HPLC Method Development and Validation for the Simultaneous Estimation of Pregabalin and Duloxetine in Pure and Pharmaceutical Dosage Form<\/title><secondary-title>International Journal of Drug Delivery Technology<\/secondary-title><\/titles><dates><year>2026<\/year><\/dates><electronic-resource-num>10.25258\/ijddt.16.18s.104<\/electronic-resource-num><urls><related-urls><url>https:\/\/doi.org\/10.25258\/ijddt.16.18s.104<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>13<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Tesfaye S<\/author><author>Sloan G<\/author><author>Petrie J et al.<\/author><\/authors><\/contributors><titles><title>Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial.<\/title><secondary-title>Lancet (London, England)<\/secondary-title><\/titles><dates><year>2022<\/year><\/dates><electronic-resource-num>10.1016\/S0140-6736(22)01472-6<\/electronic-resource-num><urls><related-urls><url>http:\/\/www.thelancet.com\/article\/S0140673622014726\/pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>14<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Bragg S<\/author><author>Marrison ST<\/author><author>Haley S<\/author><\/authors><\/contributors><titles><title>Diabetic Peripheral Neuropathy: Prevention and Treatment.<\/title><secondary-title>American family physician<\/secondary-title><\/titles><dates><year>2024<\/year><\/dates><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>15<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Billig JI<\/author><author>Gunaseelan V<\/author><author>Yazdanfar M et al.<\/author><\/authors><\/contributors><titles><title>Gabapentinoid Prescribing for Carpal Tunnel Syndrome.<\/title><secondary-title>Hand (New York, N.Y.)<\/secondary-title><\/titles><dates><year>2023<\/year><\/dates><electronic-resource-num>10.1177\/15589447211063544<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/9896291<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>16<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Winslow BT<\/author><author>Vandal C<\/author><author>Dang L<\/author><\/authors><\/contributors><titles><title>Fibromyalgia: Diagnosis and Management.<\/title><secondary-title>American family physician<\/secondary-title><\/titles><dates><year>2023<\/year><\/dates><\/record>\n<\/records><\/xml>\n"

"\n\nMolGod<\/database>MOL-GOD<\/source-app>1<\/rec-number>17<\/ref-type>Kaye AD<\/author>Armistead G<\/author>Amedio LS et al.<\/author><\/authors><\/contributors>Evolving Treatment Strategies for Neuropathic Pain: A Narrative Review.<\/title><secondary-title>Medicina (Kaunas, Lithuania)<\/secondary-title><\/titles><dates><year>2025<\/year><\/dates><electronic-resource-num>10.3390\/medicina61061063<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.mdpi.com\/1648-9144\/61\/6\/1063\/pdf?version=1749542630<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>2<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Fagan HA<\/author><author>Baldwin DS<\/author><\/authors><\/contributors><titles><title>Pharmacological Treatment of Generalised Anxiety Disorder: Current Practice and Future Directions.<\/title><secondary-title>Expert review of neurotherapeutics<\/secondary-title><\/titles><dates><year>2023<\/year><\/dates><electronic-resource-num>10.1080\/14737175.2023.2211767<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737175.2023.2211767?needAccess=true&role=button<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>3<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Borgert BJ<\/author><author>Wallen EM<\/author><author>Pham MN<\/author><\/authors><\/contributors><titles><title>Prostatitis: A Review.<\/title><secondary-title>JAMA<\/secondary-title><\/titles><dates><year>2025<\/year><\/dates><electronic-resource-num>10.1001\/jama.2025.11499<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>4<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Strzelczyk A<\/author><author>Schubert-Bast S<\/author><\/authors><\/contributors><titles><title>Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies.<\/title><secondary-title>CNS drugs<\/secondary-title><\/titles><dates><year>2022<\/year><\/dates><electronic-resource-num>10.1007\/s40263-022-00955-9<\/electronic-resource-num><urls><related-urls><url>https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-022-00955-9.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>5<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Safarpour Y<\/author><author>Vaziri ND<\/author><author>Jabbari B<\/author><\/authors><\/contributors><titles><title>Restless Legs Syndrome in Chronic Kidney Disease- a Systematic Review.<\/title><secondary-title>Tremor and other hyperkinetic movements (New York, N.Y.)<\/secondary-title><\/titles><dates><year>2023<\/year><\/dates><electronic-resource-num>10.5334\/tohm.752<\/electronic-resource-num><urls><related-urls><url>https:\/\/storage.googleapis.com\/jnl-up-j-tohm-files\/journals\/1\/articles\/752\/6424233a93752.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>6<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Huerta M\u00c1<\/author><author>Garcia MM<\/author><author>Garc\u00eda-Parra B et al.<\/author><\/authors><\/contributors><titles><title>Investigational Drugs for the Treatment of Postherpetic Neuralgia: Systematic Review of Randomized Controlled Trials.<\/title><secondary-title>International journal of molecular sciences<\/secondary-title><\/titles><dates><year>2023<\/year><\/dates><electronic-resource-num>10.3390\/ijms241612987<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.mdpi.com\/1422-0067\/24\/16\/12987\/pdf?version=1692511286<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>7<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Meaadi J<\/author><author>Obara I<\/author><author>Eldabe S et al.<\/author><\/authors><\/contributors><titles><title>The safety and efficacy of gabapentinoids in the management of neuropathic pain: a systematic review with meta-analysis of randomised controlled trials.<\/title><secondary-title>International journal of clinical pharmacy<\/secondary-title><\/titles><dates><year>2023<\/year><\/dates><electronic-resource-num>10.1007\/s11096-022-01528-y<\/electronic-resource-num><urls><related-urls><url>https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-022-01528-y.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>8<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>Pregabalin.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2006<\/year><\/dates><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>9<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Cernea S<\/author><author>Raz I<\/author><\/authors><\/contributors><titles><title>Management of diabetic neuropathy.<\/title><secondary-title>Metabolism: clinical and experimental<\/secondary-title><\/titles><dates><year>2021<\/year><\/dates><electronic-resource-num>10.1016\/j.metabol.2021.154867<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>10<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Tang J<\/author><author>Zhang Y<\/author><author>Liu C et al.<\/author><\/authors><\/contributors><titles><title>Therapeutic Strategies for Postherpetic Neuralgia: Mechanisms, Treatments, and Perspectives.<\/title><secondary-title>Current pain and headache reports<\/secondary-title><\/titles><dates><year>2023<\/year><\/dates><electronic-resource-num>10.1007\/s11916-023-01146-x<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>11<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>D'Souza RS<\/author><author>Barman R<\/author><author>Joseph A et al.<\/author><\/authors><\/contributors><titles><title>Evidence-Based Treatment of Painful Diabetic Neuropathy: a Systematic Review.<\/title><secondary-title>Current pain and headache reports<\/secondary-title><\/titles><dates><year>2022<\/year><\/dates><electronic-resource-num>10.1007\/s11916-022-01061-7<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>12<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Swati Shinde<\/author><author>Meena Yadav<\/author><author>Santosh waghmare<\/author><\/authors><\/contributors><titles><title>Quality by Design Based RP-HPLC Method Development and Validation for the Simultaneous Estimation of Pregabalin and Duloxetine in Pure and Pharmaceutical Dosage Form<\/title><secondary-title>International Journal of Drug Delivery Technology<\/secondary-title><\/titles><dates><year>2026<\/year><\/dates><electronic-resource-num>10.25258\/ijddt.16.18s.104<\/electronic-resource-num><urls><related-urls><url>https:\/\/doi.org\/10.25258\/ijddt.16.18s.104<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>13<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Tesfaye S<\/author><author>Sloan G<\/author><author>Petrie J et al.<\/author><\/authors><\/contributors><titles><title>Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial.<\/title><secondary-title>Lancet (London, England)<\/secondary-title><\/titles><dates><year>2022<\/year><\/dates><electronic-resource-num>10.1016\/S0140-6736(22)01472-6<\/electronic-resource-num><urls><related-urls><url>http:\/\/www.thelancet.com\/article\/S0140673622014726\/pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>14<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Bragg S<\/author><author>Marrison ST<\/author><author>Haley S<\/author><\/authors><\/contributors><titles><title>Diabetic Peripheral Neuropathy: Prevention and Treatment.<\/title><secondary-title>American family physician<\/secondary-title><\/titles><dates><year>2024<\/year><\/dates><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>15<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Billig JI<\/author><author>Gunaseelan V<\/author><author>Yazdanfar M et al.<\/author><\/authors><\/contributors><titles><title>Gabapentinoid Prescribing for Carpal Tunnel Syndrome.<\/title><secondary-title>Hand (New York, N.Y.)<\/secondary-title><\/titles><dates><year>2023<\/year><\/dates><electronic-resource-num>10.1177\/15589447211063544<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/9896291<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>16<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Winslow BT<\/author><author>Vandal C<\/author><author>Dang L<\/author><\/authors><\/contributors><titles><title>Fibromyalgia: Diagnosis and Management.<\/title><secondary-title>American family physician<\/secondary-title><\/titles><dates><year>2023<\/year><\/dates><\/record>\n<\/records><\/xml>\n"